Predictors of and survival after incident stroke in type 1 diabetes

Few studies have examined stroke risk in type 1 diabetes mellitus (T1DM). Stroke incidence, predictors, and survival were thus explored in this study. Pittsburgh Epidemiology of Diabetes Complications (EDC) Study participants (n = 658) with childhood-onset T1DM were followed biennially for 18 years. Baseline (1986–1988) mean age and diabetes duration were 28 and 19 years respectively. Stroke incidence and type was determined via survey or physician interview and, when possible, confirmed with medical or autopsy records. During follow-up, 31 (4.7%) strokes occurred (21 ischaemic, 8 haemorrhagic, 2 unclassified) in participants of mean age = 40.2 years (range 23–60). In exploratory multivariable Cox modelling, diabetes duration, systolic blood pressure (SBP), non-high density lipoprotein cholesterol (non-HDLc), white blood cells (WBC), and pulse significantly predicted ischaemic stroke. Adding overt nephropathy (ON) (hazard ratio = 4.4, 95% CI, 1.5–12.4) to the model replaced SBP. Participant survival after stroke was 80.6%, 45.2%, and 9.6% at 1, 5, and 10 years, respectively, and significantly worse after haemorrhagic stroke (p = 0.03). These risk factors merit careful evaluation and management to prevent stroke in T1DM, which occurs at least 20 years earlier than in the general population.

[1]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.

[2]  P. Henriksson,et al.  Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia. , 2010, Thrombosis research.

[3]  R. G. Miller,et al.  In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study , 2010, Diabetologia.

[4]  B. Zinman,et al.  Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005). , 2009, Archives of internal medicine.

[5]  T. Olsen,et al.  Hemorrhagic and Ischemic Strokes Compared: Stroke Severity, Mortality, and Risk Factors , 2009, Stroke.

[6]  Merlin C. Thomas,et al.  The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes , 2009, Diabetes.

[7]  J. Tamsma,et al.  Renal and retinal effects of enalapril and losartan in type 1 diabetes. , 2009, The New England journal of medicine.

[8]  J. O’Keefe,et al.  The role of renin–angiotensin–aldosterone system‐based therapy in diabetes prevention and cardiovascular and renal protection , 2008, Diabetes, obesity & metabolism.

[9]  R Peto,et al.  Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. , 2008, Lancet.

[10]  A. Folsom,et al.  Risk Factors for Intracerebral Hemorrhage in a Pooled Prospective Study , 2007, Stroke.

[11]  A. Fogo.  Mechanisms of progression of chronic kidney disease , 2007, Pediatric Nephrology.

[12]  J. Manson,et al.  Prospective Study of Type 1 and Type 2 Diabetes and Risk of Stroke Subtypes , 2007, Diabetes Care.

[13]  K. Sundquist,et al.  Type 1 diabetes as a risk factor for stroke in men and women aged 15–49: a nationwide study from Sweden , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[14]  S. Soedamah-Muthu,et al.  High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. , 2006, Diabetes care.

[15]  T. Davis,et al.  Predictors of first stroke in Type 1 diabetes: The Fremantle Diabetes Study , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[16]  J. Manson,et al.  Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. , 2005, Archives of internal medicine.

[17]  H. Keen,et al.  Risk factors for macrovascular disease in diabetes mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease in Diabetics , 1991, Diabetologia.

[18]  K. Forrest,et al.  Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. , 2003, Diabetes care.

[19]  N. Waugh,et al.  Mortality From Cerebrovascular Disease in a Cohort of 23 000 Patients With Insulin-Treated Diabetes , 2003, Stroke.

[20]  K. Forrest,et al.  Glycemia (or, in women, estimated glucose disposal rate) predict lower extremity arterial disease events in type 1 diabetes. , 2002, Metabolism: clinical and experimental.

[21]  A. T. N. Group,et al.  Risk factors for cardiovascular mortality and morbidity: The WHO multinational study of vascular disease in diabetes. , 2001, Diabetologia.

[22]  F. Nieto,et al.  Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus , 2000 .

[23]  A. Folsom,et al.  Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. , 1999, Circulation.

[24]  R. Gillum,et al.  White blood cell count and stroke incidence and death. The NHANES I epidemiologic follow-up study. , 1994, American journal of epidemiology.

[25]  L. Kuller,et al.  International Evaluation of Cause-Specific Mortality and IDDM , 1991, Diabetes Care.

[26]  L. Kuller,et al.  Prevalence of Complications in IDDM by Sex and Duration: Pittsburgh Epidemiology of Diabetes Complications Study II , 1990, Diabetes.

[27]  L. Kuller,et al.  Factors Associated With Avoidance of Severe Complications After 25 Yr of IDDM: Pittsburgh Epidemiology of Diabetes Complications Study I , 1990, Diabetes Care.

[28]  Langford Hg.  The hypertension detection and follow-up program. , 1984 .

[29]  H. Langford.  The hypertension detection and follow-up program. , 1984, New York state journal of medicine.

[30]  D. Wagener,et al.  The Pittsburgh Study of Insulin-Dependent Diabetes Mellitus: Risk for Diabetes Among Relatives of IDDM , 1982, Diabetes.

[31]  T. Deckert,et al.  Prognosis of diabetics with diabetes onset before the age of thirty-one. I. Survival, causes of death, and complications. , 1978, Diabetologia.

[32]  J. Albers,et al.  Heparin--Mn2+ quantitation of high-density-lipoprotein cholesterol: an ultrafiltration procedure for lipemic samples. , 1978, Clinical chemistry.

[33]  D. Ellis,et al.  New approach to evaluation of proteinuric states. , 1977, Clinical chemistry.

[34]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .